Sears Capital Management Overview

  • Investor Type
  • Venture Capital

  • Status
  • Inactive

  • Professionals
  • 1

Professionals
  • Investments
  • 48

  • Portfolio
  • 3

  • Exits
  • 44

Exits

Sears Capital Management General Information

Description

Founded in 1994, Sears Capital Management is a venture capital firm based in Cupertino, California. The firm seeks to invest in pharmaceuticals and medical devices companies and specializes in the life sciences sector.

Contact Information

Year Founded
1994
Investor Status
Not Making New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 20370 Town Center Lane
  • Suite 120
  • Cupertino, CA 95014
  • United States
+1 (650) 000-0000

Sears Capital Management Investments (48)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
AN2 Therapeutics 21-Nov-2019 Early Stage VC 0000 Drug Discovery Clinical Trials - Phase 1
0000 000000000000 08-Apr-2017 00000 00000 00.000 Drug Discovery Out of Business 000000 00000
0000000 0000000000 08-Jan-2017 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 000000 00000
000000 01-Mar-2016 00000 00000 0000 Therapeutic Devices Generating Revenue
0000000 0000000000 16-Jul-2015 00000 00000 00.00 Drug Discovery Clinical Trials - Phase 1 000000 00000
0000000 0000000000 23-Sep-2014 00000 00000 00.00 Drug Discovery Clinical Trials - Phase 1 000000 00000
0000000 0000000 30-Apr-2014 00000 00000 Drug Discovery Startup 000000 00000
00000 000000000 05-Mar-2014 00000 00000 000.00 Drug Discovery Generating Revenue
SoundFocus 19-Feb-2014 Seed Round 00.00 Application Software Bankruptcy: Liquidation
Cellerant Therapeutics 21-Sep-2012 Later Stage VC 00.000 Drug Discovery Profitable 000000 00000
You’re viewing 10 of 48 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sears Capital Management Exits (44)

Company Name Exit Date Exit Type Exit Size
AN2 Therapeutics 25-Mar-2022 IPO 0000
0000 000000000000 10-Mar-2020 000 00 00000000
0000000 0000000 01-Jan-2020 000000000 00000000
000000 18-Jun-2019 000000000000000000
000000 0000000 01-Mar-2019 000 00 00000000
00000000 000000000 31-Jan-2017 000000000000000000 0000
0000000000 18-May-2016 0000000000: 000000
00000 000000000 17-Apr-2014 000 0000
CoAlign Innovations 31-Mar-2014 Merger/Acquisition
InteKrin 12-Feb-2014 Merger/Acquisition 000
You’re viewing 10 of 44 exits. Get the full list »

Sears Capital Management Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Sears Capital Management Team (1)

Name Title Deals Funds Boards Office
Lowell Sears Chairman, Chief Executive Officer and and Chief Investment Officer 00 0 Cupertino, CA
To view Sears Capital Management’s complete team members history, request access »

Sears Capital Management Co-Investors (8)

Name With Exits Lead Partner Series Industry
Adjuvant Capital 1 0 Series chart Industry bar
BioRock Ventures 0 0 Series chart Industry bar
Brii Biosciences 0 Series chart Industry bar
Mountain Group Partners 0 0 Series chart Industry bar
Vinny Sica 0 0 Series chart Industry bar
You’re viewing 5 of 8 co-investors. Get the full list »